VISEN Pharmaceuticals (HKG:2561)
32.00
+0.50 (1.59%)
Mar 10, 2026, 3:59 PM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 3.31 billion as of March 9, 2026.
Market Cap
3.31B
Enterprise Value
2.43B
Revenue
921.55K
Ranking
n/a
PE Ratio
n/a
Stock Price
32.00
Market Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 3.31B, a decrease of -54.02%. That is a compound annual growth rate of -55.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.37B | -2.26% |
| Dec 31, 2025 | 3.44B | -52.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hua Medicine (Shanghai) | 3.10B |
| Jacobson Pharma Corporation | 2.56B |
| Essex Bio-Technology | 2.29B |
| Golden Throat Holdings Group Company | 2.27B |
| JBM (Healthcare) | 2.22B |
| Edding Genor Group Holdings | 5.34B |
| Dawnrays Pharmaceutical (Holdings) | 1.74B |
| China Shineway Pharmaceutical Group | 6.90B |